
FDA approves weight-management drug Contrave.
The US FDA has approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The … Continue Reading FDA approves weight-management drug Contrave.